[Value of dolasetron mesilate in treatment of postoperative nausea and vomiting].
Badaoui
R
R
Yagoubi
A
A
Carpentier
F
F
Riboulot
M
M
Ossart
M
M
D000328:Adult; D000932:Antiemetics / Q000009:adverse effects / Q000627:therapeutic use*; D002763:Cholecystectomy; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007211:Indoles / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008787:Metoclopramide / Q000009:adverse effects / Q000627:therapeutic use; D020250:Postoperative Nausea and Vomiting / Q000188:drug therapy*; D011807:Quinolizines / Q000009:adverse effects / Q000627:therapeutic use*; D012702:Serotonin Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome
D000932:Antiemetics; D007211:Indoles; D011807:Quinolizines; D012702:Serotonin Antagonists; C060344:dolasetron; D008787:Metoclopramide
Apport du mésilate de dolasétron dans le traitement des nausées et vomissements postopératoires.